BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26861951)

  • 1. Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease.
    Xu L; Ma L; Lian J; Yang J; Chen S
    Mol Med Rep; 2016 Mar; 13(3):2729-35. PubMed ID: 26861951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
    Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
    PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
    Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels.
    Blokzijl H; Vander Borght S; Bok LI; Libbrecht L; Geuken M; van den Heuvel FA; Dijkstra G; Roskams TA; Moshage H; Jansen PL; Faber KN
    Inflamm Bowel Dis; 2007 Jun; 13(6):710-20. PubMed ID: 17262809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD99 refers to the activity of inflammatory bowel disease.
    Zhou G; Yang W; Yu L; Yu T; Liu Z
    Scand J Gastroenterol; 2017 Mar; 52(3):359-364. PubMed ID: 27866429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
    Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
    J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.
    Molnár K; Vannay A; Szebeni B; Bánki NF; Sziksz E; Cseh A; Győrffy H; Lakatos PL; Papp M; Arató A; Veres G
    World J Gastroenterol; 2012 Jul; 18(25):3254-9. PubMed ID: 22783049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.
    Palmieri O; Mazzoccoli G; Bossa F; Maglietta R; Palumbo O; Ancona N; Corritore G; Latiano T; Martino G; Rubino R; Biscaglia G; Scimeca D; Carella M; Annese V; Andriulli A; Latiano A
    Chronobiol Int; 2015; 32(7):903-16. PubMed ID: 26172092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
    Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
    Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of IL-16 in inflammatory bowel disease.
    Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
    Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.